icddr,b’s research leads to approval of fourth single dose HPV vaccine

The CVIA 087 (CHOISES) trial, conducted in collaboration with PATH, icddr,b, and partners in Ghana between 2021-23, has generated critical data on Cecolin, a bivalent HPV vaccine produced by...